Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Sheng Yang

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Neurology|July 26, 2013
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis opticaChun-Sheng Yang, Li Yang, Ting Li, et al.
Biomaterials|December 17, 2013
Graphene oxide doped conducting polymer nanocomposite film for electrode-tissue interfaceHong-Chang Tian, Jing-Quan Liu, Dai-Xu Wei, et al.
Therapeutic Advances in Neurological Disorders|February 16, 2026
Thymectomy with or without maintenance therapy for myasthenia gravis patients: a tri-center, real-world studyHao Zhang, Moli Fan, Yutong Shi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2016
Augmentation of Circulating Follicular Helper T Cells and Their Impact on Autoreactive B Cells in Myasthenia GravisCun-Jin Zhang, Ye Gong, Wenli Zhu, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 9, 2024
A Simple Score (MOG-AR) to Identify Individuals at High Risk of Relapse After MOGAD AttackYun Xu, Huaxing Meng, Moli Fan, et al.
Frontiers in Public Health|September 11, 2024
Clinical features of COVID-19 infection in patients with myasthenia gravis: a real-world retrospective studyHui-Ning Li, Xiao-Na Xu, Ying-Hui Qin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 7, 2020
Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disordersMoli Fan, Wei Qiu, Bitao Bu, et al.
The Lancet. Neurology|April 26, 2020
Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trialChao Zhang, Meini Zhang, Wei Qiu, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Neurology|July 26, 2013
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis opticaChun-Sheng Yang, Li Yang, Ting Li, et al.
Biomaterials|December 17, 2013
Graphene oxide doped conducting polymer nanocomposite film for electrode-tissue interfaceHong-Chang Tian, Jing-Quan Liu, Dai-Xu Wei, et al.
Therapeutic Advances in Neurological Disorders|February 16, 2026
Thymectomy with or without maintenance therapy for myasthenia gravis patients: a tri-center, real-world studyHao Zhang, Moli Fan, Yutong Shi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2016
Augmentation of Circulating Follicular Helper T Cells and Their Impact on Autoreactive B Cells in Myasthenia GravisCun-Jin Zhang, Ye Gong, Wenli Zhu, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 9, 2024
A Simple Score (MOG-AR) to Identify Individuals at High Risk of Relapse After MOGAD AttackYun Xu, Huaxing Meng, Moli Fan, et al.
Frontiers in Public Health|September 11, 2024
Clinical features of COVID-19 infection in patients with myasthenia gravis: a real-world retrospective studyHui-Ning Li, Xiao-Na Xu, Ying-Hui Qin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 7, 2020
Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disordersMoli Fan, Wei Qiu, Bitao Bu, et al.
The Lancet. Neurology|April 26, 2020
Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trialChao Zhang, Meini Zhang, Wei Qiu, et al.
Pageof 6